Anh Tu Nguyen

Insider Reports History

Location
Chicago, IL
Signature
/s/ Beth Hecht, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anh Tu Nguyen:

Company Role Class Num Shares Value Price $ Report Date Ownership
Xeris Biopharma Holdings, Inc. Chief Medical Officer Common Stock 395,023 $2,717,758 $6.88 24 Feb 2026 Direct
Xeris Biopharma Holdings, Inc. Chief Medical Officer Common Stock 3,710 $27,899 $7.52 24 Feb 2026 By IRA
Xeris Biopharma Holdings, Inc. Chief Medical Officer Common Stock 3,501 $26,327 $7.52 24 Feb 2026 By children's IRA
Xeris Biopharma Holdings, Inc. Chief Medical Officer Stock Option (Right to Buy) 162,162 30 Jan 2026 Direct

Insider Reports Filed by Anh Tu Nguyen

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XERS Xeris Biopharma Holdings, Inc. 24 Feb 2026 1 -$201,584 4 Chief Medical Officer 25 Feb 2026, 18:03
XERS Xeris Biopharma Holdings, Inc. 30 Jan 2026 2 $0 4 Chief Medical Officer 02 Feb 2026, 18:11
XERS Xeris Biopharma Holdings, Inc. 25 Feb 2025 0 $0 3 Chief Medical Officer 07 Mar 2025, 16:11